Join us from November 29 to December 1, 2025, for three days of cutting-edge sessions, expert talks, and interactive discussions across four dynamic programs: Vascular ART Main Auditorium, Round Table Discussion, Vascular ART Theater, and Limb Rescue Room.
A PDF version of the program and the agenda are available for download
Who Really Is “No-Go” for Surgery? – Defining High-Risk in 2025
1) How do we define inoperability in the era of advanced anesthesia and hybrid approaches?
2) Role of scoring systems (e.g., SAPPHIRE) vs. clinical judgment
3) Are some "no-go" patients actually "no-try"?
Amr Gad-Egypt
15:15- 15:30
Carotid Artery Stenting (CAS) in High-Risk Patients – Still a Reasonable First Line?
1) Current evidence on CAS outcomes in symptomatic high-risk patients
2) Device evolution: embolic protection, closed-cell vs. open-cell stents
3) Can we personalize the decision beyond anatomy?
Abdullah Alhaizaey-KSA
15:30- 15:45
Surgical Techniques in High-Risk Carotid Patients – Should We Modify the Operation?
1) Conventional vs. eversion endarterectomy: when and why
2) Local vs. general anesthesia, shunt use, neuro-monitoring
3) Can tailoring the surgical technique expand eligibility?
Martin Storck-Germany
15:45- 16:00
Medical Management Alone – Still a Valid Option in 2025?
1) For patients who can’t tolerate or refuse revascularization
2) Role of dual antiplatelets, statins, and plaque stabilization
3) Risk stratification for stroke recurrence under conservative management
Abdullah Alhaizaey-KSA
Amr Gad-Egypt
Martin Storck-Germany
Who Really Ǫualifies for DVA? – Patient Selection in No-Option CLI
1) Clear indications and gray zones: when is DVA justified?
2) Angio some concept vs. global foot perfusion
3) Role of WIFI, GLASS, and PROMISE II criteria
Hany Zayed-UK
11:15- 11:30
Tools and Techniques: How Are We Doing It in Real Life?
1) Dedicated DVA systems (e.g., LimFlow) vs. off-label DIY approaches
2) Surgical vs. percutaneous: access, crossing, and re-entry strategies
3) Key intra-procedural steps: arterialization targets, valves, flow control
Maria Antonella Ruffino-Switzerland
11:30- 11:45
Literature Check – What Do the Trials and Registries Say? Bruno Migliara-Italy
1) PROMISE I ł II, APEX, ALPS: what are they really telling us?
2) Patency, limb salvage, wound healing rates
3) Is there truly a survival benefit in no-option CLI?
Bruno Migliara-Italy
11:45- 12:00
The Follow-Up Challenge – Managing the DVA Patient Beyond the Procedure
1) Surveillance protocols: clinical, duplex, and imaging
2) When to intervene on failing flow? When to amputate?
3) Role of podiatry, wound care, and multidisciplinary teams
Bruno Migliara-Italy
Hany Zayed-UK
Maria Antonelli-Switzerland
Red Flags After EVAR – When Does “Watchful Waiting” Become Dangerous?
1) Identifying failure early: sac expansion, Type I/III endoleaks, loss of seal
2) Role of imaging follow-up: how often and what modality?
3) Defining “failed EVAR” in clinical practice
Wael Tawfik-UK
12:15- 12:30
Salvage Endovascular Tactics – Are We Pushing It Too Far?
1) Chimney, snorkel, endoanchors, relining: tools or desperation?
2) When to say "enough" with endo-fixation strategies
3) Are we risking rupture by delaying conversion?
Vicente Riambau-Spain
12:30- 12:45
The Open Conversion – When, How, and By Whom?
1) Technical aspects: total vs. partial explant, suprarenal fixation issues
2) High-risk patient profiles: is open conversion feasible?
3) The role of hybrid surgeons and tertiary referral centers
Murad Sallam-UK
12:45- 13:00
Guidelines vs. Real Life – Who Sets the Line in the Sand?
1) What current guidelines recommend – and their limitations
2) Case-based experience: borderline calls and decision algorithms
3) Creating institutional protocols for EVAR failure management
Landing Zones, Sizing, and Wall Apposition – Are We Getting It Right?
1) Identifying healthy distal landing zones in post-thrombotic disease
2) The challenge of “true lumen” tracking in chronic occlusion
3) IVUS vs. venography for sizing and length determination
4) In-stent restenosis: sizing errors or biology?
Abdelrahman Salem-Egypt
14:15- 14:30
Complex Iliocaval Reconstruction – How Far Can We Go?
1) Crossing long-standing occlusions: best wires, sheaths, and snaring tricks
2) Managing iliocaval confluence and May-Thurner overlap
3) Handling filters, high bifurcations, duplicated systems
4) Single vs. kissing stents in bilateral disease
Michael Lichtenberg-Germany
14:30- 14:45
Venous Hybrid OR – How to Set It Up for Success
1) What your Angio room must have: table, access, support staff
2) Patient positioning, dual access techniques
3) Tools checklist: from recanalization to ballooning and stenting
Tanie Saez Guzman-UAE
14:45- 15:00
Post-Stenting Protocols and Pitfalls – What Should We All Be Doing?
1) Anticoagulation and antiplatelet strategy: is there a consensus?
2) Surveillance: when, how often, and with what imaging?
3) Re-thrombosis, mis deployment, kinking – how to avoid and manage
4) When to reintervene vs. wait-and-see: literature vs. experience
Abdelrahman Salem-Egypt
Michael Lichtenberg-Germany
Tanie Saez Guzman-UAE
Uncomplicated Type B: Surveillance or Preemptive TEVAR? Updated guidelines: when is “uncomplicated” really safe?
1) Predictors of late aneurysmal degeneration: who’s at risk?
2) Is early TEVAR reshaping long-term outcomes?
3) Role of dynamic imaging in early risk stratification
David Wells-UK
15:15- 15:30
The Shearing Zone: Managing the Bird-Beak and Arch Challenges
1) Importance of proximal landing zones in the arch (Zone 2/3)
2) Bird-beak configuration: predictors and solutions
3) Role of left subclavian artery management (revascularization or coverage?)
4) New stent-graft technologies for better arch apposition
Abdullah Alhaizaey-KSA
15:30 -15:45
Fenestration , Petticoat , Distal Perfusion , What works Best ?
1) PETTICOAT technique: still relevant or outclassed?
2) Endovascular adjuncts for distal true lumen expansion
3) Combining TEVAR with distal bare stents: evidence and technique .
Mohamed Elkassaby-Ireland
15:45 -16:00
When TEVAR fails or not Enough ? What are the other Option?
1) Persistent malperfusion: when to escalate
2) Open conversion: when and how to plan
3) Complications post-TEVAR: retrograde dissection, endoleaks, stent-induced injury
4) Life after TEVAR: imaging surveillance, reintervention planning
Ali Badra
Abdullah Alhaizaey-KSA
David Wells-UK
Mohamed Elkassaby-Ireland
Acute DVT: Who Benefits from Early Intervention?
1) Recent clinical models and stratification for selecting patients for endovascular vs. medical therapy.
2) When thrombolysis, thrombectomy, or hybrid approaches make a difference.
3) Should iliofemoral DVT always prompt a more aggressive approach?
Mohamed Hagag-Egypt
11:15- 11:30
Filters in the Modern Era: Still a Place or Phasing Out?
1) Current guideline recommendations: IVC filter indications and retrieval timelines.
2) Are we overusing filters in fear of PE?
3) Innovations in retrievable and bio convertible filters — what's changing?
Ahmed Gawesh-Egypt
11:30- 11:45
PTS Prevention and Management: Are We Failing?
1) What role do endovascular tools play in reducing long-term PTS?
2) The role of compression, ambulation, and anticoagulation: do we have the right protocols?
3) Updates on scoring systems and objective PTS assessment.
Atef Abdelhamid-Egypt
11:45- 12:00
Anticoagulation and Antiplatelets in DVT/PTS: One Size Fits All?
1) NOACs in DVT: Are they enough in preventing PTS or recurrence?
2) Is there a role for dual therapy (anticoagulants + antiplatelets) in certain cases?
3) Duration of therapy — how long is long enough?
The Comeback of Open Surgery: Indications That Still Require the Scalpel
1) Which cases clearly mandate surgical repair in the era of stents?
2) Complex aortic pathology, hostile necks, infected endografts: still teach and train Surgery
3) Can surgical durability compete with endovascular convenience?
Ahmed Nassef-UK
12:15- 12:30
The Hybrid Approach: Choosing the Right Tool for the Right Zone
1) When and how to combine open and endovascular techniques effectively.
2) Value of well-planned hybrid ORs and surgical readiness.
3) Does hybrid training define the future vascular specialist?
Hassan Ahmad Alzahrani-KSA
12:30- 12:45
Open Bypass vs. Endo for Peripheral Artery Disease: Who Really Wins Long-Term?
1) Does the BASIL-2 trial change practice or confirm bias?
2) How to select patients for bypass — conduit quality, distal target, and disease burden.
3) Real-world limb salvage outcomes: is endo being overused?
Hussein Barayan-KSA
12:45- 13:00
Training Crisis? The Future of Vascular Surgery in an Endovascular World
1) Are we producing enough confident open surgeons?
2) Residency and fellowship training: balancing open case numbers with endo competency.
3) Should surgical simulation and modular training become standard?
Endovascular Robotics – Hype or Game Changer?
• What's currently possible vs. future potential in robotic-assisted vascular intervention.
• Are robotic platforms ready for widespread adoption in complex cases?
• Will this increase access in underserved areas?
TBD
14:15- 14:30
AI in Imaging, Planning, and Intra-Op Guidance – Friend or Foe?
• Can AI outperform human planning in PAD or aneurysm sizing?
• Role of AI in fusion imaging, procedural navigation, and risk prediction.
• Is there a risk of over-reliance or misinterpretation?
TBD
14:30- 14:45
From Generative AI to Predictive Modeling – How Far Can We Go in Vascular Medicine?
• Role of AI in clinical decision support, follow-up strategy, and patient education.
• Can predictive models (e.g., limb loss risk, aneurysm growth) improve outcomes?
• Ethical concerns: bias, data ownership, transparency
TBD
14:45- 15:00
Will the Vascular Surgeon of 2035 Need to Code or Just Collaborate?
• Should vascular trainees learn data science, simulation, or automation tools?
• Interdisciplinary future: engineering, machine learning, surgery.
• What skills make the future vascular leader: technical precision or system mastery?
